CINCINNATI--(BUSINESS WIRE)--Dec. 10, 2008--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today
announced that Jack Kraeutler, Chief Executive Officer, will be
presenting as a panel participant at the RBC Capital Markets 2008
Healthcare Conference, held at the Westin Times Square Hotel in New
York. The panel titled, Getting to the Point (of Care) is
scheduled from 9-9:55 a.m. ET. on December 11, 2008 in Panel Room 2. The
information provided during the session may not have been previously
A live webcast of the panel will be available on the Events section of
the Investor Relations page of Meridian's website at www.meridianbioscience.com.
A replay of the webcast will be available for 30 days following the
Certain statements may be made at the conference that may be considered
"forward-looking statements" within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934. Actual results could differ materially from any predictions that
may be made. Additional information regarding factors that could cause
such differences shall be referenced at the conference.
Meridian is a fully integrated life science company that manufactures,
markets and distributes a broad range of innovative diagnostic test
kits, purified reagents and related products and offers
biopharmaceutical enabling technologies. Utilizing a variety of methods,
these products and diagnostic tests provide accuracy, simplicity and
speed in the early diagnosis and treatment of common medical conditions,
such as gastrointestinal, viral and respiratory infections. Meridian's
diagnostic products are used outside of the human body and require
little or no special equipment. The Company's products are designed to
enhance patient well-being while reducing the total outcome costs of
healthcare. Meridian has strong market positions in the areas of
gastrointestinal and upper respiratory infections, serology,
parasitology and fungal disease diagnosis. In addition, Meridian is a
supplier of rare reagents, specialty biologicals and related
technologies used by biopharmaceutical companies engaged in research for
new drugs and vaccines. The Company markets its products and
technologies to hospitals, reference laboratories, research centers,
veterinary testing centers, physician offices, diagnostics manufacturers
and biotech companies in more than 60 countries around the world. The
Company's shares are traded through NASDAQ's Global Select Market,
symbol VIVO. Meridian's website address is www.meridianbioscience.com.
CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, Chief Executive Officer
Source: Meridian Bioscience, Inc.